1/2 Collaborative Union for Cancer Research, Education and Disparities (CURED)

1/2 癌症研究、教育和差异合作联盟 (CURED)

• 批准号: 10762265
• 负责人: Veronica B Ajewole
• 金额: $ 30.01万
• 依托单位: BAYLOR COLLEGE OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-09-21 至 2027-08-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10762265
• 关键词: Address; Advisory Committees; African American; Area; Cancer Center; Career Choice; Collaborations; Communities; Community Health Education; Community Outreach; Comprehensive Cancer Center; Cost Allocation; Data; Degree program; Development; Disparity; Education; Education and Outreach; Educational Curriculum; Effectiveness; Emerging Technologies; Ensure; Environment; Evaluation; Exposure to; Facilities and Administrative Costs; Faculty; Fostering; Funding; Funding Agency; Goals; Health Disparities Research; Historically Black Colleges and Universities; Infrastructure; Institution; Joints; Lead; Leadership; Malignant Neoplasms; Medical center; Medicine; Mentors; Minority Health Research; National Cancer Institute; Pilot Projects; Prevention; Process; Program Development; Research; Research Peer Review; Research Personnel; Resources; Schools; Science; Students; Texas; Training; Training Support; Underrepresented Students; Underserved Population; United States National Institutes of Health; Universities; anticancer research; cancer education; cancer health disparity; career; career development; college; cost; design; education research; empowerment; ethnic diversity; experience; graduate student; higher education; improved; innovation; member; outreach; outreach program; programs; research and development; summer student; undergraduate student; university student

CURED Overall Abstract Dan L Duncan Comprehensive Cancer Center (DLDCCC) at Baylor College of Medicine (BCM) and Texas Southern University (TSU) are jointly submitting a P20 application to build a collaborative partnership in cancer research, education, and outreach. DLDCCC is a National Cancer Institute (NCI) designated cancer center. TSU is one of the nation’s largest Historically Black Colleges and Universities (HBCU) serving underserved populations and underrepresented students (ISUPSs). BCM and TSU have had several successful collaborations. This relationship was strengthened recently through TSU’s U54 “Center for Biomedical and Minority Health Research”, where BCM faculty have partnered closely on collaborative cancer disparities community education and outreach. This P20 program provides an excellent opportunity for TSU and BCM to expand collaborations. We propose a BCM-TSU P20 program “Collaborative Union for Cancer Research, Education and Disparities” (CURED) that will foster strong collaborations utilizing our complementary strengths. Overall objectives are to create a shared infrastructure that will provide an optimal environment for cancer research, education, community outreach, and career development and diversify the biomedical workforce. CURED was established under the direction of senior leadership at each institution, reflected in the significant institutional support for this partnership. BCM has committed $160,000/year for four years in cost matching funds, $ 50,000 for Pilot project 2 for one year, and committed funds to support the training of TSU summer students in the Cancer Research Education Program. TSU has committed to return the Indirect Cost allocation amounting to $98,000 each year. All TSU investigators are members of the DLDCCC. Leaders of each institution are thus committed to empower the P20 partnership to address cancer health disparities among URM and underserved populations in Houston. Our goals are to (1) establish a collaborative alliance between BCM and TSU for cancer research, education, and community outreach. We will (a) establish CURED offices in both institutions that will provide coordination for relevant activities, evaluate progress of current projects, and ensure a pipeline of innovative pilot projects; (b) centralize institutional resources for faculty/trainee research needs (c) lead a cancer research and career development program for TSU students that includes mentored cancer research, an educational curriculum, hands-on training in emerging technologies, and professional development; (d) build a BCM/TSU comprehensive outreach program to address cancer disparities at the bench, bedside, and within the community; and (2) to support a pipeline of collaborative innovative cancer research pilot projects. Overall Impact: We are certain that the proposed CURED will enhance cancer research education capacity at TSU, promote a diverse research workforce, and improve BCM/DLDCCC’s effectiveness in developing and sustaining research programs focused on cancer health disparities. We will develop sustainable research capacity leading to independent and collaborative applications to the NIH/other Federal/Non-federal agencies.

总体摘要 贝勒医学院（BCM）和德克萨斯州的Dan L邓肯综合癌症中心（DLDCCC） 南方大学（大津）联合提交P20申请，建立癌症合作伙伴关系 研究、教育和推广。DLDCCC是美国国家癌症研究所（NCI）指定的癌症中心。大津 是全国最大的历史上黑人学院和大学（HBCU）服务不足之一 人口和代表性不足的学生（ISUPSs）。在过去的几年里， 合作。这种关系最近通过大津的U 54“生物医学中心和 少数民族健康研究”，在那里，研究人员在合作癌症差异方面密切合作 社区教育和外联。这个P20计划为大津和TSU提供了一个极好的机会， 扩大合作。我们提出了一个BCM-TSU P20计划“癌症研究合作联盟， 教育和差距”（治愈），这将促进利用我们的互补优势强大的合作。 总体目标是创建一个共享的基础设施，为癌症提供最佳环境 研究、教育、社区推广和职业发展，并使生物医学劳动力多样化。 在每个机构的高级领导的指导下，建立了CURED，反映在重要的 为这一伙伴关系提供机构支持。联合国已承诺在四年内每年提供160 000美元的成本匹配资金， 50 000美元用于试点项目2，为期一年，并承诺提供资金支持大津暑期学生的培训 癌症研究教育项目大津已承诺退还间接费用分配， 每年98,000美元。所有大津研究者均为DLDCCC成员。因此，每个机构的领导人 致力于增强P20伙伴关系的能力，以解决URM和服务不足者之间的癌症健康差距 休斯顿的人口。我们的目标是（1）建立一个合作联盟之间的癌症研究所和大津 研究、教育和社区外展。我们将（a）在这两个机构设立“消除种族歧视、仇外心理和相关不容忍现象”办事处， 为相关活动提供协调，评估当前项目的进展情况，并确保 创新试点项目;（B）集中机构资源，满足教职员/实习生的研究需求;（c）领导癌症 研究和职业发展计划的大津学生，包括指导癌症研究， 教育课程、新兴技术的实践培训和专业发展;（d）建立一个 美国癌症协会/大津的综合外展计划，以解决癌症在板凳上的差异，床边，并在 （2）支持一系列合作创新癌症研究试点项目。 总体影响：我们确信，拟议的治愈将提高癌症研究教育能力， 大津，促进多样化的研究队伍，并提高农业部/DLDCCC在开发和 持续的研究项目集中在癌症健康的差异。我们将发展可持续的研究 能力，导致独立和协作应用到NIH/其他联邦/非联邦机构。